CA25525-3 - 0x0000000000003AB8

Males & Females of Non-Childbearing Potential

Rose

* Stipend may pay up to reflected amount.
Start Date: 
March 12, 2019 - 3:00pm
End Date: 
March 20, 2019 - 7:30am

Study Details

Study Number: CA25525
Group Number: 3
Study Requirement: Healthy Male
Stipend: $2,000.00

Study Criteria

Age: 19 - 65
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat a genetic disorder in which bone gradually replaces muscle tissue.
Route of Administration: Oral
Blood Draws: 19

Study Schedule

Schedule Type: Short stays with returns
Study Length: One - 5 Night Stay & 1 Return

Screening Dates

Event Day Event Date
Friday 3/1/2019

Doctor Exam Dates:H4>

Event Day Event Date
Friday 3/1/2019

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Tuesday 3/12/2019 3:00:00 PM Sunday 3/17/2019 7:30:00 AM 1 Lincoln
Return Wednesday 3/20/2019 6:30:00 AM Wednesday 3/20/2019 7:30:00 AM 1 Lincoln